FdaApplication
BLA 761432
Identifiers
- fda_app_no: BLA761432
Properties
| Property | Value |
|---|---|
| applicant_name | Merck Sharp & Dohme LLC |
| application_type | BLA |
| approval_date | 2025-06-09 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ENFLONSIA | CLESROVIMAB-CFOR | 105MG/0.7ML | Injection |
1 product